GlassScriptPhysician profile
Arianna D'Angelo
NPI 1295295053
$435.42
in general payments reported to CMS, 2019-2025
10 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $66.30 · 2024: $169 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $120.53 | 2024 | Sogroya |
| Millicent US INC | $112.15 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Abbvie INC. | $36.60 | 2024-2025 | |
| Organon LLC | $36.33 | 2023-2025 | Jada System, Nexplanon |
| Sumitomo Pharma America, INC. | $35.09 | 2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $30.26 | 2025 | |
| Astellas Pharma US INC | $20.96 | 2025 | Veozah |
| Exeltis, USA INC. | $15.65 | 2024 | Slynd |
| Optumhealth Care Solutions, LLC | $14.20 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Olympus America INC. | $13.65 | 2025 | Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arianna D'Angelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.